Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ProStrakan agrees to acquire Archimedes Pharma
Archimedes Pharma is a UK-based pharmaceutical firm that provides treatments within the therapeutic areas of pain, oncology and critical care. PecFent, Archimedes’ fentanyl nasal spray, is used in
Archimedes Pharma is a UK-based pharmaceutical firm that provides treatments within the therapeutic areas of pain, oncology and critical care. PecFent, Archimedes’ fentanyl nasal spray, is used in
The company said that Aptiom is not indicated for use in patients under 18 years of age. The approval is based on three Phase III randomized, double-blind, placebo-controlled,
Beloranib is a potent inhibitor of Methionine aminopeptidase-2 that reduces hunger while stimulating the use of stored fat as an energy source (MetAP2), which is an enzyme that
As part of the deal, the partners will share the costs and risks of discovery and development of new drugs as well as jointly own intellectual property and
The company said that EVZIO is not a substitute for emergency medical care and it is approved by the US Food and Drug Administration (FDA) in April 2014.
The move follows BMS’ discussions with FDA and will mark the second tumor type for which the company has a regulatory submission underway for Opdivo in the US.
The company said that ATX-101 NDA, which was submitted in May 2014, will be subject to a standard review and will have a Prescription Drug User Fee Act
About 76 individuals with T1D, younger than 30 years of age and with HbA1c levels greater than 9.0%, are expected to be randomly assigned to receive either placebo
Under the deal, the company expects that the ‘contract manufacturer’ will be able to offer sufficient manufacturing capacity at cGMP production facilities to allow commercialization of its treatment
The company said that the NDA filing is a significant achievement for its Infectious Disease franchise and, if approved, isavuconazole will be another tool used to combat these